Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11945804 Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith

Patent 11945804 was granted and assigned to Celgene on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Dehua Huang0

Matthew D. Correa0

Soraya Carrancio0

Joshua Hansen0

Veronique Plantevin-Krenitsky0

Antonia Lopez-Girona0

Virginia Heather Sharron Grant0

Timothy S. Kercher0

...

Date of Patent

April 2, 2024

0

Patent Application Number

177433130

Date Filed

May 12, 2022

0

Patent Citations

US Patent 9598669 Composition for collecting placental stem cells and methods of using the composition

0

US Patent 7091353 Isoindole-imide compounds, compositions, and uses thereof

0

US Patent 8518972 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same

0

US Patent 8957065 Fused pyrimidine derivatives for inhibition of tyrosine kinase activity

0

US Patent 9090585 2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds

0

US Patent 10357489 Antiproliferative compounds and methods of use thereof

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11945804 Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool